Caption Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-65,000
Closed -$7.22M – 1762
2025
Q3
$7.22M Sell
65,000
-72,000
-53% -$8.18M 0.06% 370
2025
Q2
$15.2M Buy
137,000
+57,000
+71% +$6.07M 0.17% 122
2025
Q1
$8.96M Buy
+80,000
New +$8.25M 0.09% 230
2024
Q1
– Sell
-32,500
Closed -$2.63M – 1373
2023
Q4
$2.63M Sell
32,500
-27,100
-45% -$2.11M 0.04% 531
2023
Q3
$4.47M Buy
59,600
+27,100
+83% +$2.08M 0.07% 345
2023
Q2
$2.5M Sell
32,500
-8,000
-20% -$638K 0.04% 438
2023
Q1
$3.36M Buy
+40,500
New +$3.35M 0.06% 319
2022
Q4
– Sell
-99,000
Closed -$6.11M – 1424
2022
Q3
$6.11M Buy
+99,000
New +$6.24M 0.08% 278
2022
Q1
– Sell
-200,000
Closed -$14.5M – 1635
2021
Q4
$14.5M Buy
200,000
+100,000
+100% +$6.89M 0.16% 157
2021
Q3
$6.98M Buy
100,000
+70,000
+233% +$4.92M 0.08% 334
2021
Q2
$2.06M Buy
+30,000
New +$2M 0.03% 667
2019
Q4
– Sell
-50,000
Closed -$3.17M – 906
2019
Q3
$3.17M Buy
+50,000
New +$3.27M 0.16% 170
2018
Q4
– Sell
-250,000
Closed -$19.3M – 519
2018
Q3
$19.3M Buy
+250,000
New +$18.9M 1.06% 11

Other funds holding GILD

Caption Management's GILD Position: Q3 2026 in Review

Caption Management sold out of Gilead Sciences (GILD) in Q3 2026, closing a stake of 100,000 shares — an estimated $12.6M sold.

Caption Management first reported a position in GILD in Q3 2019 and held it in 10 quarters. The position peaked at $16.5M in Q2 2025. 2,332 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Caption Management reported no remaining Gilead Sciences position as of Q3 2026 after selling out during the quarter.
  • Caption Management sold 100,000 Gilead Sciences shares in Q3 2026, an estimated $12.6M.
  • Caption Management first reported a position in Gilead Sciences in Q3 2019 and held it in 10 quarters.
  • Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
  • 2,332 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.